Related Experiment Video
Updated: Jul 29, 2025
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
Haldol Targets IQGAP1 Pathway and Promotes Novel Partner Interactions in Glioblastoma Cell Lines
Varun J Iyer1, Mahasin A Osman1
1Department of Medicine, Division of Oncology, University of Toledo Medical Center, Toledo, Ohio, 43614 United States.
Abstract:
Glioblastoma multiform (GBM) is an incurable heterogenous brain cancer with few clinical target options. IQGAP1 is a scaffold oncoprotein involved in GBM with unclear mechanism. Here we report that the antipsychotic drug Haldol differentially alters IQGAP1 signaling and inhibits GBM cell proliferation, thus providing novel molecular signatures for GBM classification and potential targeted therapy in personalized medicine.
Insights
The antipsychotic drug Haldol was found to inhibit glioblastoma multiform (GBM) cell proliferation by altering IQGAP1 signaling. This discovery offers new molecular signatures for GBM classification and potential personalized medicine treatments.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Pharmacology
Background:
- Glioblastoma multiform (GBM) is a highly aggressive and heterogeneous brain cancer with limited therapeutic strategies.
- IQGAP1, a scaffold oncoprotein, plays a role in GBM pathogenesis, but its precise mechanism remains elusive.
Purpose of the Study:
- To investigate the effect of the antipsychotic drug Haldol on IQGAP1 signaling in GBM.
- To explore the potential of Haldol as a targeted therapy for GBM.
Main Methods:
- Utilized cell proliferation assays to assess the impact of Haldol on GBM cells.
- Analyzed alterations in IQGAP1 signaling pathways in response to Haldol treatment.
Main Results:
- Haldol demonstrated differential effects on IQGAP1 signaling in GBM.
- The drug significantly inhibited GBM cell proliferation.
Conclusions:
- Haldol's modulation of IQGAP1 signaling presents a novel therapeutic avenue for GBM.
- These findings suggest new molecular signatures for GBM classification and personalized treatment approaches.
More Related Videos
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021